#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

The Follow up of Prognostic Important Factors and Analysis of Five Years Survival Rate in Patients with Uveal Melanoma at the Department of Ophthalmology, 3rd Medical Faculty, Charles University in Prague and the Faculty Hospital Královské Vinohrady in Prague


Authors: M. Ředinová Vokrojová 1;  J. Šach 2;  D. Baráková 3;  P. Kuchynka 1;  J. Vránová 4
Authors‘ workplace: Oftalmologická klinika 3. LF UK a FNKV, přednosta prof. MUDr. P. Kuchynka, CSc. 1;  Ústav patologie 3. LF UK a FNKV, přednosta prof. MUDr. V. Mandys, CSc. 2;  Cornea Lexum, s. r. o., Praha, přednosta doc. MUDr. D. Baráková, CSc. 3;  Ústav lékařské biofyziky a lékařské informatiky 3. LF UK, přednosta doc. MUDr. J. Rosina 4
Published in: Čes. a slov. Oftal., 65, 2009, No. 1, p. 29-35

Overview

The analysis of survival and the influence of the followed up prognostic important factors to the duration of survival in 51 patients with uveal melanoma, treated by enucleation of the eyeball was evaluated by means of Kaplan – Meier analysis and Cox regression model.

The study was performed at the Department of Ophthalmology of the 3rd Medical Faculty, Charles University in Prague and the Faculty Hospital Královské Vinohrady in Prague, Czech Republic, E.U., during the period 1999 to 2007. The mortality rate with the association to the general diagnosis was 35.5 %. By means of the statistical analysis of survival, (Kaplan – Meier analysis) we established that these followed up prognostic factors are important for the duration of the survival period: pTNM (pathologic tumor-node-metastasis) (p = 0.00032), the size of the tumor (p = 0.01603), mitotic activity (p = 0.028889), and the rupture of the Bruch’s membrane (p = 0.1446). The Cox regression model specifying which of the independent entry values correlates mostly with the period of survival, or the date of death respectively, showed that the strongest correlations with the period of survival duration had in our group the pTNM classification.

Key words:
uveal melanoma, survival rate, prognostic important factors


Sources

1. Avery, R.B., Diener-West, M., Reynolds, S.M.: Histopathologic Characteristics of Uveal Melanoma in Eyes Enucleated After Iodine 125 Brachytherapy in the Collaborative Ocular Melanoma Study. Arch Ophthalmol., 126, 2008; 2: 207-212

2. Baráková, D.: Nitrooční tumory. Grada Publishing, Praha 2002, s. 152

3. Coleman, K., Baak, J.A., Van Diest, P.: Prognostic factors following enucleation of 111 uveal melanomas. Br J Ophthalmol., 77, 1993: 688-692

4. Collaborative Ocular Melanoma Study Group: Histopathologic Characteristics of Uveal melanomas in Eyes Enucleated From the Collaborative Ocular Melanoma Study: COMS Report No 6. Am J Ophthalmol., 125, 1998: 745-766

5. Isager, P., Ehlers, N.: Overgaard J. Prognostic factors for survival after enucleation for choroidal and ciliary body melanomas. Acta Ophthalmol Scand., 82, 2004: 517-525

6. Souček, P.: Nitrooční nádory. In Kuchynka, P. a kol.: Oční lékařství. Grada Publishing, Praha 2007, s.479-500

7. Seddon, J.M., Albert, D.M., Lavin, P.T., et al.: A prognostic factor study of disease-free interval and survival following enucleation for uveal melanoma. Arch Ophthalmol., 101, 1983: 1894-1899

8. Sobin, L.H., Wittekind, C. (ed.): TNM klasifikace zhoubných novotvarů, 6. vydání 2002, česká verze 2004. A John Willey and Sons, Inc., New York 2002, česká verze Ústav zdravotnických informací a statistiky ČR 2004, str.181-3

9. Šach, J., Křepelková, J.: Prognosticky významné rysy uveálního melanomu v histopatologickém vyšetření. Čs.Oftal., 48, 1992; 6: 412-418

10. Šach, J.: Histopatologie. In Kuchynka, P., a kol.: Oční lékařství. Grada Publishing, Praha 2007, s.61-97

11. Virgili, G., Gatta, G., Cicollalo, L.: Incidence of Uveal Melanoma in Europe. Ophthalmology, 114, 2007: 2309-2315

Labels
Ophthalmology

Article was published in

Czech and Slovak Ophthalmology

Issue 1

2009 Issue 1

Most read in this issue
Login
Forgotten password

Enter the email address that you registered with. We will send you instructions on how to set a new password.

Login

Don‘t have an account?  Create new account

#ADS_BOTTOM_SCRIPTS#